Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms

NCT05732961 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Myeloproliferative Neoplasm
Anemia

Interventions

DRUG: Luspatercept

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]